Literature DB >> 6321606

Pneumocystis carinii pneumonia in renal-transplant recipients treated with cyclosporine and steroids.

A M Hardy, C P Wajszczuk, A F Suffredini, T R Hakala, M Ho.   

Abstract

Fourteen of 156 renal-transplant recipients treated with cyclosporine and steroids developed Pneumocystis carinii-related pneumonia (PCP) over a 19-month period. This was a significant change from past experience with this disease in renal-transplant patients receiving azathioprine and steroids (six cases among 179 patients from 1977 to 1981). Epidemiological investigation failed to implicate either person-to-person or nosocomial spread of infection. Cases of PCP occurred more frequently in males. Twelve patients (86%) had onset of disease in the third or fourth months after transplantation. Comparison of cases to matched controls revealed that the cases had received lower doses of steroids and had a higher incidence of cytomegalovirus infection. This suggested that the cases may have been more effectively immunosuppressed than the controls. After institution of prophylaxis with trimethoprim-sulfamethoxazole, no further cases of PCP developed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6321606     DOI: 10.1093/infdis/149.2.143

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  23 in total

Review 1.  Update on the diagnosis and treatment of Pneumocystis pneumonia.

Authors:  Eva M Carmona; Andrew H Limper
Journal:  Ther Adv Respir Dis       Date:  2010-08-24       Impact factor: 4.031

2.  Detection of Pneumocystis carinii DNA in air samples: likely environmental risk to susceptible persons.

Authors:  M S Bartlett; S H Vermund; R Jacobs; P J Durant; M M Shaw; J W Smith; X Tang; J J Lu; B Li; S Jin; C H Lee
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

Review 3.  Prevention of infection due to Pneumocystis carinii.

Authors:  J A Fishman
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

Review 4.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

5.  Infection with human immunodeficiency virus in the Pittsburgh transplant population. A study of 583 donors and 1043 recipients, 1981-1986.

Authors:  J S Dummer; S Erb; M K Breinig; M Ho; C R Rinaldo; P Gupta; M V Ragni; A Tzakis; L Makowka; D Van Thiel
Journal:  Transplantation       Date:  1989-01       Impact factor: 4.939

6.  Immunodetection of Pneumocystis carinii in bronchoalveolar lavage specimens compared with methenamine silver stain.

Authors:  I Lautenschlager; O Lyytikainen; L Jokipii; A Jokipii; A Maiche; T Ruutu; P Tukiainen; P Ruutu
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

Review 7.  Pneumocystis carinii pneumonia.

Authors:  J T Macfarlane; R G Finch
Journal:  Thorax       Date:  1985-08       Impact factor: 9.139

8.  Does cyclosporin A adversely affect Pneumocystis carinii infection?

Authors:  R J McGonigle; M Beaman; J Stone; J Young; J Michael; D Adu
Journal:  Postgrad Med J       Date:  1988-09       Impact factor: 2.401

Review 9.  Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients.

Authors:  Martin Rodriguez; Jay A Fishman
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

10.  Outbreak of Pneumocystis carinii pneumonia in a renal transplant unit.

Authors:  C Hennequin; B Page; P Roux; C Legendre; H Kreis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-02       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.